New PBS listing welcomed by dermatologists

Australians suffering from the chronic skin condition hidradenitis suppurativa (HS) now have access to a new class of drug without the hefty price tag.

Adalimumab (Humira) a tumor necrosis factor-inhibiting, anti-inflammatory, biologic medication has been listed on the PBS for the treatment of chronic, inflammatory disease.